KalVista Pharmaceuticals
KALV
KALV
94 hedge funds and large institutions have $310M invested in KalVista Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.14% more ownership
Funds ownership: 98.68% → 100.82% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
23% less call options, than puts
Call options by funds: $740K | Put options by funds: $959K
Holders
94
Holding in Top 10
4
Calls
$740K
Puts
$959K
Top Buyers
| 1 | +$6.85M | |
| 2 | +$6.46M | |
| 3 | +$2.61M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.66M |
| 5 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
+$1.22M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$1.89M | |
| 3 | -$1.83M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
-$1.53M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.39M |